Session Details
Poster Session 8 Chemotherapy for Advanced Colorectal Cancer 1
Fri. Nov 20, 2026 2:00 PM - 3:00 PM JST
Fri. Nov 20, 2026 5:00 AM - 6:00 AM UTC
Fri. Nov 20, 2026 5:00 AM - 6:00 AM UTC
ポスター4
座長：古畑 智久（札幌禎心会病院）
[P8-1]A case in which a large amount of ascites was recognized during postoperative adjuvant chemotherapy with CapeOX and struggled to diagnose
*Toshitada Fujita1 (1. Department of Surgery,Hyogo Prefectural Tamba Medical Center)
[P8-2]Sustained Progression-Free Status After Discontinuation of Pembrolizumab Following a Marked Response in MSI-High Stage IV Ascending Colon Cancer
*Nobuo Takiguchi1 (1. Rinku General Medical Center)
[P8-3]Treatment Outcomes of Adjuvant Chemotherapy for Stage II Colon Cancer at Our Hospital
*Miyako Tazawa1 (1. Department of Gastrointestinal surgery, Tsuchiura Kyodo General Hospital)
[P8-4]A case of MSI-High colorectal cancer with distant lymph node metastasis showing a remarkable response to Pembrolizumab
*Takuya Tamura1 (1. International University of Health and Welfare Narita Hospital)
[P8-5]Characteristics and Outcomes of Patients with Colorectal Cancer Undergoing Resection During Second-line Chemotherapy for Stage IV or Recurrent Metastatic Disease
*Miki Shindo1 (1. Department of Gastroenterological Surgery, Osaka University Hospital)
[P8-6]Safety and Efficacy of Oral Tyrosine Kinase Inhibitors Following Trifluridine/Tipiracil Plus Bevacizumab Therapy in Patients with Unresectable Advanced or Recurrent Colorectal Cancer
*Shami Kazuki1 (1. Division of Gastroenterology and Hepatology, Department of Internal Medicine, Keio University School of Medicine)